Literature DB >> 10935938

Impairment of colour vision in workers exposed to organic solvents.

S Semple1, F Dick, A Osborne, J W Cherrie, A Soutar, A Seaton, N Haites.   

Abstract

OBJECTIVES: To investigate loss of colour vision related to exposure to solvents and the role of three enzyme polymorphisms in modifying the risk in exposed workers.
METHODS: A sample was studied of 68 male dockyard workers and 42 male community controls with and without neuropsychological symptoms from a previous cross sectional study. Indices of cumulative and intensity based exposure to solvents were calculated for all subjects. Alcohol, drug, and smoking histories were obtained. Colour vision was tested by Lanthony D15d colour vision test. Genotype of glutathione S-transferase M1 and T1 and N-acetyltransferase 2 polymorphisms were determined.
RESULTS: The relation between impairment of colour vision and exposure to solvents was investigated with multiple regression techniques. Increasing annual exposure to solvents was significantly associated with reduced colour vision (p=0.029). Impairment of colour vision was not associated with neuropsychological symptoms as measured by the Q16 solvent symptom questionnaire. No significant association was found between acquired impairment of colour vision and genetic polymorphisms when GSTM1, GSTT1 or NAT2 phenotypes were included in the analyses.
CONCLUSIONS: Exposure to mixed solvents is associated with impairment in colour vision, the risk increases with increasing exposure. The risk of impairment of colour vision was not altered in this study by the presence of different GSTM1, GSTT1 or NAT2 polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935938      PMCID: PMC1740009          DOI: 10.1136/oem.57.9.582

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  28 in total

1.  Neuropsychological function in retired workers with previous long-term occupational exposure to solvents.

Authors:  W E Daniell; K H Claypoole; H Checkoway; T Smith-Weller; S R Dager; B D Townes; L Rosenstock
Journal:  Occup Environ Med       Date:  1999-02       Impact factor: 4.402

2.  Neuropsychological symptoms in Chinese male and female painters: an epidemiological study in dockyard workers.

Authors:  R Chen; L Wei; A Seaton
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

3.  Health effects of solvent exposure among dockyard painters: mortality and neuropsychological symptoms.

Authors:  R Chen; F Dick; A Seaton
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

4.  Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy.

Authors:  P Söderkvist; A Ahmadi; A Akerbäck; O Axelson; U Flodin
Journal:  Scand J Work Environ Health       Date:  1996-10       Impact factor: 5.024

5.  Quantitative assessment of color vision impairment in workers exposed to toluene.

Authors:  M Zavalić; Z Mandić; R Turk; A Bogadi-Sare; D Plavec
Journal:  Am J Ind Med       Date:  1998-03       Impact factor: 2.214

6.  Assessing color vision loss among solvent-exposed workers.

Authors:  D Mergler; L Blain
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

7.  Chromal focus of acquired chromatic discrimination loss and solvent exposure among printshop workers.

Authors:  D Mergler; S Bélanger; S De Grosbois; N Vachon
Journal:  Toxicology       Date:  1988-05       Impact factor: 4.221

8.  The desaturated panel D-15.

Authors:  P Lanthony
Journal:  Doc Ophthalmol       Date:  1978-10-16       Impact factor: 2.379

9.  A method for quantitative scoring of the Farnsworth Panel D-15.

Authors:  K J Bowman
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-12

10.  Chronic toxic encephalopathy in a painter exposed to mixed solvents.

Authors:  R G Feldman; M H Ratner; T Ptak
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

View more
  7 in total

1.  Exposure to organic solvents and personality.

Authors:  R Chen; F Dick; S Semple; A Seaton; L G Walker
Journal:  Occup Environ Med       Date:  2001-01       Impact factor: 4.402

2.  The neuro-ophthalmological effects related to long-term occupational exposure to organic solvents in painters.

Authors:  Heba Khodary Allam; Shaimaa Soliman; Tamer Wasfy; Ahmed Ghoneim; Yasser Serag; Grace Sembajwe
Journal:  Toxicol Ind Health       Date:  2017-11-14       Impact factor: 2.273

3.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

4.  Psychophysical evaluation of achromatic and chromatic vision of workers chronically exposed to organic solvents.

Authors:  Eliza Maria da Costa Brito Lacerda; Monica Gomes Lima; Anderson Raiol Rodrigues; Cláudio Eduardo Correa Teixeira; Lauro José Barata de Lima; Dora Fix Ventura; Luiz Carlos de Lima Silveira
Journal:  J Environ Public Health       Date:  2011-12-15

5.  Long-term occupational exposure to organic solvents affects color vision, contrast sensitivity and visual fields.

Authors:  Thiago Leiros Costa; Mirella Telles Salgueiro Barboni; Ana Laura de Araújo Moura; Daniela Maria Oliveira Bonci; Mirella Gualtieri; Luiz Carlos de Lima Silveira; Dora Fix Ventura
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

6.  Organic solvent exposure and contrast sensitivity: comparing men and women.

Authors:  A R Oliveira; A A Campos Neto; M J O de Andrade; P C B de Medeiros; N A Dos Santos
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

7.  Chronic Organic Solvent Exposure Changes Visual Tracking in Men and Women.

Authors:  Ana R de Oliveira; Armindo de Arruda Campos Neto; Paloma C Bezerra de Medeiros; Michael J O de Andrade; Natanael A Dos Santos
Journal:  Front Neurosci       Date:  2017-11-30       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.